# Study of ADI-PEG 20 in Patients With Advanced Melanoma

> **NCT00520299** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ludwig Institute for Cancer Research** · enrollment: 31 (actual)

## Conditions studied

- Metastatic Melanoma
- Skin Cancer
- Neoplasm

## Interventions

- **DRUG:** ADI PEG 20

## Key facts

- **NCT ID:** NCT00520299
- **Lead sponsor:** Ludwig Institute for Cancer Research
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2022-10-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00520299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00520299, "Study of ADI-PEG 20 in Patients With Advanced Melanoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00520299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*